Dnd medical - Company finances
|
EUR
|
2024
From: 2024-02-27
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 94,934 | 1,034,395 |
| Profit before tax | 1,166 | 47,274 |
| Net profit | 981 | 39,667 |
| Equity | 1,981 | 41,647 |
| Liabilities | 58,994 | 186,867 |
| Non-current assets | 0 | 39,600 |
| Current assets | 60,975 | 188,914 |
| Total assets | 60,975 | 228,514 |
|
Taxes paid
|
||
| STI taxes | 3,163 | 27,184 |
|
Financial indicators
|
||
| Revenue change y/y | - | +989.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.6% | 17.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 49.5% | 95.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 3.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.2% | 4.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 29.8 | 4.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 1,034,395 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dnd medical - Social security debts
The company had no debts to Sodra
Dnd medical - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-08-08 | 2025-08-12 | 392.37 |
| 2024-12-20 | 2024-12-20 | 609.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dnd medical, MB (company code 306689555) is a small partnership engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €1.03M and net profit of €39.7K, with a profit margin of 3.8%. Revenue increased sharply year on year by 989.6% from €94.9K in 2024, when net profit was €981. The 2-year trajectory shows a move from a very small turnover base in 2024 to materially higher activity in 2025, together with a clear improvement in profitability. At the end of 2025, total assets stood at €228.5K, equity at €41.6K and liabilities at €186.9K. Key ratios indicate high asset efficiency and leverage, including return on equity of 95.2%, return on assets of 17.4%, debt-to-equity of 4.49 and asset turnover of 4.53x. Revenue per employee was €1.03M, and profit per employee was €39.7K.